These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22633783)

  • 1. The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects.
    Dohil R; Meyer L; Schmeltzer S; Cabrera BL; Lavine JE; Phillips SA
    J Pediatr; 2012 Oct; 161(4):639-45.e1. PubMed ID: 22633783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.
    Dohil R; Schmeltzer S; Cabrera BL; Wang T; Durelle J; Duke KB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2011 May; 33(9):1036-44. PubMed ID: 21395631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating pediatric nonalcoholic fatty liver disease with cysteamine: is adiponectin the key?
    Xanthakos SA; Kohli R
    J Pediatr; 2012 Oct; 161(4):579-81. PubMed ID: 22738945
    [No Abstract]   [Full Text] [Related]  

  • 4. Disparity in circulating adiponectin multimers between term and preterm infants.
    Siahanidou T; Margeli A; Garatzioti M; Davradou M; Apostolakou F; Papassotiriou I; Mandyla H
    J Perinat Med; 2009; 37(6):683-8. PubMed ID: 19591556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle- and high-molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease.
    Lian K; Feng YN; Li R; Liu HL; Han P; Zhou L; Li CX; Wang Q
    J Clin Lab Anal; 2020 Apr; 34(4):e23148. PubMed ID: 31880002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.
    von Eynatten M; Liu D; Bluemm A; Schuster T; Baumann M; Lutz J; Heemann U; Dugi KA; Nawroth PP; Bierhaus A; Humpert PM
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):27-32. PubMed ID: 18778396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases.
    Ebinuma H; Miyazaki O; Yago H; Hara K; Yamauchi T; Kadowaki T
    Clin Chim Acta; 2006 Oct; 372(1-2):47-53. PubMed ID: 16697359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease.
    Louthan MV; Barve S; McClain CJ; Joshi-Barve S
    J Pediatr; 2005 Dec; 147(6):835-8. PubMed ID: 16356442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apelin levels in subjects with nonalcoholic fatty liver disease.
    Ercin CN; Dogru T; Tapan S; Kara M; Haymana C; Karadurmus N; Karslioglu Y; Acikel C
    Metabolism; 2010 Jul; 59(7):977-81. PubMed ID: 20045153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin multimeric forms but not total adiponectin levels are associated with myocardial infarction in non-diabetic men.
    Baessler A; Schlossbauer S; Stark K; Strack C; Riegger G; Schunkert H; Hengstenberg C; Fischer M
    J Atheroscler Thromb; 2011; 18(7):616-27. PubMed ID: 21512277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adiponectin multimer complexes and liver cancer risk in a large cohort study in Japan.
    Kotani K; Wakai K; Shibata A; Fujita Y; Ogimoto I; Naito M; Kurozawa Y; Suzuki H; Yoshimura T; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():87-90. PubMed ID: 20553088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
    Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
    Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults.
    O'Leary VB; Jorett AE; Marchetti CM; Gonzalez F; Phillips SA; Ciaraldi TP; Kirwan JP
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E421-7. PubMed ID: 17488807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects.
    Salani B; Briatore L; Andraghetti G; Adami GF; Maggi D; Cordera R
    Obesity (Silver Spring); 2006 Sep; 14(9):1511-4. PubMed ID: 17030961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin profiles are affected by chronic and acute changes in carbohydrate intake in healthy cats.
    Tan HY; Rand JS; Morton JM; Fleeman LM; Armstrong PJ; Coradini M; Ishioka K; Verkest KR; Richards AA; Rawlings JM; Rose FJ; Whitehead JP
    Gen Comp Endocrinol; 2011 Jul; 172(3):468-74. PubMed ID: 21530529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease.
    Tapan S; Dogru T; Kara M; Ercin CN; Kilciler G; Genc H; Sertoglu E; Acikel C; Kilic S; Karslioglu Y; Kurt I; Erbil MK
    Scand J Clin Lab Invest; 2010 Oct; 70(6):399-403. PubMed ID: 20604719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease].
    Yang H; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Hong Y
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):525-8. PubMed ID: 17669243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.